LBP AM’s Bristol-Myers Squibb BMY Stock Holding History

LBP AM’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12M	Buy	208,620 +38,295	+22%	+$2.2M	0.12%	156
2026 Q1	$10.3M	Sell	170,325 -147,721	-46%	-$8.61M	0.14%	148
2025 Q4	$17.2M	Sell	318,046 -56,713	-15%	-$2.73M	0.2%	102
2025 Q3	$16.9M	Sell	374,759 -15,780	-4%	-$737K	0.21%	96
2025 Q2	$18.1M	Sell	390,539 -33,180	-8%	-$1.63M	0.25%	80
2025 Q1	$25.8M	Sell	423,719 -15,400	-4%	-$898K	0.4%	56
2024 Q4	$24.8M	Buy	439,119 +90,586	+26%	+$5.06M	0.34%	64
2024 Q3	$18M	Buy	348,533 +278,644	+399%	+$13.1M	0.27%	77
2024 Q2	$2.9M	Buy	69,889 +16,383	+31%	+$733K	0.12%	136
2024 Q1	$2.9M	Sell	53,506 -446,239	-89%	-$22.7M	0.12%	146
2023 Q4	$25.6M	Sell	499,745 -73,482	-13%	-$3.86M	0.57%	47
2023 Q3	$33.3M	Buy	573,227 +23,838	+4%	+$1.46M	0.74%	32
2023 Q2	$35.1M	Buy	549,389 +450,564	+456%	+$30.2M	0.83%	29
2023 Q1	$6.85M	Sell	98,825 -4,550	-4%	-$321K	0.17%	120
2022 Q4	$7.44M	Buy	+103,375	New	+$7.79M	0.21%	101

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LBP AM's BMY Position: Q2 2026 in Review

LBP AM increased its Bristol-Myers Squibb (BMY) stake by 22% in Q2 2026, buying an estimated $2.2M and bringing the position to 208,620 shares worth $12M. The position accounts for 0.12% of the portfolio, ranked #156.

LBP AM first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $35.1M in Q2 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

LBP AM held 208,620 shares of Bristol-Myers Squibb worth $12M as of Q2 2026.
LBP AM bought 38,295 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.2M.
Bristol-Myers Squibb made up 0.12% of LBP AM's portfolio in Q2 2026, its #156 holding.
LBP AM first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
LBP AM's Bristol-Myers Squibb position peaked at $35.1M in Q2 2023.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.